L773:2235 3186 OR L773:1660 8151
Search: L773:2235 3186 OR L773:1660 8151 > (2005-2009) > Erythropoietin impa...
- 1 of 2
- Previous record
- Next record
- To hitlist
- Annuk, MargusUppsala universitet,Institutionen för medicinska vetenskaper (author)
Erythropoietin impairs endothelial vasodilatory function in patients with renal anemia and in healthy subjects
- Article/chapterEnglish2006
Publisher, publication year, extent ...
- 2005-09-16
- S. Karger AG,2006
- printrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:uu-79889
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-79889URI
- https://doi.org/10.1159/000088308DOI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- Background/Aim: The mechanisms underlying the aggravation or development of hypertension frequently seen during treatment of renal anemia with epoetins are not fully elucidated. The aim of the present study was to investigate the effects of epoetin alfa on endothelial vasodilatory function in patients with renal anemia and in healthy subjects. Methods: Eighteen preuremic patients with anemia (GFR 23.4 ± 11 SD ml/min, Hb 101 ± 8 g/l) and 10 healthy subjects underwent evaluation of endothelium-dependent vasodilation (EDV) and endothelium-independent vasodilation (EIDV) by means of forearm blood flow (FBF) measurements with venous occlusion plethysmography during local intra-arterial infusions of methacholine (MCh, evaluating EDV) and sodium nitroprusside (SNP, evaluating EIDV). These investigations were performed before and 30 min after an intravenous injection of epoetin alfa (10,000 IU). Ten healthy subjects underwent the same procedure with the exception that saline were given instead of epoetin. The patients were treated with epoetin alfa subcutaneously for 12-19 weeks and revaluated when Hb exceeded 120 g/l. Results: EDV was attenuated after the epoetin injection in both renal patients and healthy subjects. This impairment persisted after anemia had been treated. EDIV and blood pressure remained constant. Saline had no effect on the variables measured. Conclusion: Our results indicate that epoetin alfa impairs endothelial function in renal patients and healthy subjects which may have an impact on vascular complications.
Subject headings and genre
- Chronic renal failure
- Endothelium
- Epoetin alfa
- MEDICINE
- MEDICIN
Added entries (persons, corporate bodies, meetings, titles ...)
- Linde, TorbjörnUppsala universitet,Institutionen för medicinska vetenskaper(Swepub:uu)torblind (author)
- Lind, LarsUppsala universitet,Institutionen för medicinska vetenskaper,Akut- och internmedicin(Swepub:uu)larslind (author)
- Fellström, BengtUppsala universitet,Institutionen för medicinska vetenskaper(Swepub:uu)bengfell (author)
- Uppsala universitetInstitutionen för medicinska vetenskaper (creator_code:org_t)
Related titles
- In:Nephron. Clinical practice: S. Karger AG102:1, s. c30-c341660-81512235-31861660-2110
Internet link
Find in a library
- Nephron. Clinical practice (Search for host publication in LIBRIS)
To the university's database
- 1 of 2
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Annuk, Margus
- Linde, Torbjörn
- Lind, Lars
- Fellström, Bengt
- Articles in the publication
- Nephron. Clinica ...
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
